Nicholas Yarnall
General Partner at Stellifi VC
Austin, Texas
Nicholas Yarnall, General Partner at Stellifi VC is an active investor based in Austin, Texas. This profile covers what Nicholas Yarnall backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VC
- Stages
- SeedSeries A
- Invests in
- PropTech & Real Estate
- Location
- Austin, Texas
- Typical check
- $625K
How to reach Nicholas Yarnall
Angels and operators like Nicholas Yarnall reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Nicholas Yarnall
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Nicholas Yarnall invest in?
Nicholas Yarnall invests in PropTech & Real Estate, typically at Seed and Series A. Match your sector and stage, then reach out with a personalized pitch.
What stage does Nicholas Yarnall invest at?
Nicholas Yarnall typically invests at Seed and Series A. Lead with traction that fits the stage when you reach out.
What is Nicholas Yarnall's typical check size?
Nicholas Yarnall typically writes checks around $625K. Use it as a signal for whether your raise fits their stage.
How do I contact Nicholas Yarnall?
Unlock Nicholas Yarnall's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.